Want to join the conversation?
Drugmaker $VRTX reported a narrower 1Q16 loss driven by product revenue from cystic fibrosis treating drugs Orkambi and Kalydeco. Net loss narrowed to $41.63MM or $0.17 per share from $198.61MM or $0.83 per share last year. Revenue grew to $398.08MM from $138.51MM. Non-GAAP EPS was $0.09 compared to loss of $0.62 per share a year ago.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.